The effects of Eculizumab on the pathology of malignant atrophic papulosis
Cynthia M. Magro(Cornell University), Maria T. DeSancho(NewYork–Presbyterian Hospital)
Cited by 68
Related Papers
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
|Translational research|2020|2.3k
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
|Clinical Immunology|2020|128
Severe COVID-19: A multifaceted viral vasculopathy syndrome
|Annals of Diagnostic Pathology|2020|109
The differing pathophysiologies that underlie COVID‐19‐associated perniosis and thrombotic retiform purpura: a case series
|British Journal of Dermatology|2020|107
Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura
|British Journal of Haematology|2012|99